{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:paridiprubart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02957266: Phase 3 Interventional Unknown status Cervical Cancer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04028063: Phase 2 Interventional Recruiting Metastatic Soft Tissue Sarcoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00505635: Phase 2 Interventional Terminated Melanoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02226146: Phase 2 Interventional Completed Pemphigoid, Bullous
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00743002: Phase 2 Interventional Completed Diabetes Mellitus, Type 2
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01873404: Phase 2 Interventional Completed Painful Lumbar Radiculopathy
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01996267: Phase 3 Interventional Active, not recruiting Breast Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02785900: Phase 3 Interventional Terminated Acute Myeloid Leukemia
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04123613: Phase 2 Interventional Completed Kidney Diseases
(2019)
Source URL:
Class:
PROTEIN
